We at Oxford PharmaGenesis are interested in exploring technological innovations in scientific publishing. If you work in the pharmaceutical industry, academia or publishing, we are keen to obtain your input. This short survey (less than 5 minutes estimated completion time) is designed to help us to understand your perspective on publishing innovations. This will guide our project to make scientific publishing faster, cheaper and more transparent. The survey is anonymous, and the deadline for completion is close of business on Tuesday 31 January.

Question Title

* 1. How satisfied are you with the current system for publishing industry-sponsored research?

Question Title

* 2. Which of the following aspects of the current system do you find unsatisfactory?

Question Title

* 3. In your opinion, which of the following factors are most important when selecting a journal to submit your research paper to?

Question Title

* 4. Would you view the proliferation of the following features of innovative publishing platforms as damaging or beneficial to you in your role?

  Very damaging Damaging Neutral Beneficial Very beneficial
Low journal fees
Open access 
Open peer-review (in which reviewers' comments are published alongside the article)
Post-publication peer-review
Pre-prints 
Publication of non-standard outputs (e.g. posters, slides, research notes)
Short time from submission to publication

Question Title

* 5. Does your organization have policies in place regarding any of the following?
If so, please describe these policies.

Question Title

* 6. Which of the following groups do you think would benefit if industry-sponsored research were published using innovative digital publishing platforms?

Question Title

* 7. Do you have concerns about anything specific to the pharmaceutical industry surrounding the growth of innovative digital publishing platforms?

Question Title

* 8. Thank you very much for your participation. If you would be happy to discuss this topic with us in more detail, please provide your email address, together with any further thoughts, in the box below.

T